FDA Brief

Company record

New Life Pharma LLC

1 FDA warning letter since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about New Life Pharma LLC.

Warning letters

  1. New Life Pharma LLC

    New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.

    High risk

Recalls

ReportedClassFirmProduct and reason
Mar 11 Class II New Life Pharma LLC
Drug
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Lack of Assurance of Sterility
Mar 11 Class II New Life Pharma LLC
Drug
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Lack of Assurance of Sterility
Mar 11 Class II New Life Pharma LLC
Drug
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Lack of Assurance of Sterility
Mar 11 Class II New Life Pharma LLC
Drug
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
Lack of Assurance of Sterility